This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN A. KOLMER, M.D.; ANNA M. RULE; MARY L. WERNER

Arch Otolaryngol. 1938;27(5):519-534.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The remarkable success of sulfanilamide (para-aminobenzenesulfonamide) and its derivatives in the treatment of experimental and human infections due to beta hemolytic streptococci, and to some extent of those due to pneumococci, has given rise to the hope that these preparations will prove effective in the treatment of streptococcic and pneumococcic meningitis, especially in view of the high mortality of these diseases (as high as 97 per cent in the case of streptococcic meningitis, as shown in a recent survey by Gray¹).

In February 1936 Caussé, Loiseau and Gisselbrecht² reported the recovery of a man with streptococcic meningitis of otitic origin following the intravenous and oral administration of a derivative of sulfanilamide (prontosil). The experimental work reported here was begun in January 1937, immediately after the publication of the paper by Long and Bliss³ on the remarkable effects in the treatment of mice with septicemia due to beta hemolytic streptococci. Since . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

From the Research Institute of Cutaneous Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?